Donepezil Hydrochloride
NDC 50228-139, Donepezil Hydrochloride, tablet, film coated, from ScieGen Pharmaceuticals, Inc..
- Product NDC
- 50228-139
- Status
- Listed
- Labeler
- ScieGen Pharmaceuticals, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203907
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50228-139 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DONEPEZIL HYDROCHLORIDE5 mg/1
Pharmacologic classes
Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50228-139-10 | 50228013910 | 1000 TABLET, FILM COATED in 1 BOTTLE (50228-139-10) |
| 50228-139-30 | 50228013930 | 30 TABLET, FILM COATED in 1 BOTTLE (50228-139-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/6e9aacf9-abb6-4dec-9a8d-4eabf934d512
Use it
Look up 50228-139 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50228-139 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50228-139. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.